Jeewanjot Singh | Drug Discovery | Young Scientist Award

Young Scientist Award

Jeewanjot Singh
Researcher Jeewanjot Singh
Affiliation Desh Bhagat University
Country India
Scopus ID 59955293600
Documents 4
Citations 15
h-index 2
Subject Area Drug Discovery
Event International Young Scientists Award
ORCID 0009-0000-6290-9250

Jeewanjot Singh

Desh Bhagat University, India

Jeewanjot Singh is affiliated with Desh Bhagat University, India, and has developed an emerging academic profile in the interdisciplinary field of Drug Discovery. His published research contributes to the understanding of pharmaceutical sciences, medicinal chemistry, and modern approaches used in identifying and optimizing biologically active compounds. According to the available Scopus author metrics, the researcher has produced four indexed publications that have collectively received fifteen citations while maintaining an h-index of two, reflecting the early impact of his scholarly work within specialized research communities.[1]

Abstract

The academic profile of Jeewanjot Singh reflects an emerging contribution to drug discovery and pharmaceutical research through peer-reviewed publications indexed in international scientific databases. His research demonstrates interest in identifying therapeutic compounds, understanding biological mechanisms, and supporting evidence-based pharmaceutical innovation. Although still at an early stage of his research career, the available publication and citation indicators illustrate continuous scholarly engagement and growing international visibility. These achievements form an appropriate foundation for consideration within academic recognition programs that acknowledge promising young researchers.[1]

Keywords

Drug Discovery, Pharmaceutical Sciences, Medicinal Chemistry, Therapeutic Research, Scientific Publications, Scopus Author, Young Researcher, Biomedical Innovation, Research Excellence, International Young Scientists Award.

Introduction

Drug discovery represents one of the most demanding areas of biomedical research because it integrates chemistry, biology, pharmacology, computational science, and clinical knowledge. Researchers working in this discipline contribute to identifying novel therapeutic compounds, improving existing medicines, and addressing global health challenges through systematic scientific investigation. Early-career researchers play an important role in advancing innovative concepts and supporting collaborative research environments. The documented research activities of Jeewanjot Singh illustrate participation in this evolving scientific landscape through internationally indexed publications and measurable scholarly impact.[2]

Research Profile

Jeewanjot Singh is associated with Desh Bhagat University and maintains an internationally indexed Scopus author profile. His research portfolio currently includes four Scopus-indexed documents with fifteen citations and an h-index of two. These metrics indicate developing academic visibility and demonstrate that his publications have attracted attention from researchers working in related scientific disciplines. His ORCID profile further supports transparent researcher identification and facilitates international scholarly collaboration.[1]

Research Contributions

  • Contributed to research associated with modern drug discovery methodologies.
  • Participated in pharmaceutical and medicinal chemistry investigations.
  • Published peer-reviewed research indexed within Scopus.
  • Supported evidence-based scientific communication through internationally accessible publications.

Publications

The available bibliometric information indicates four indexed publications within the field of drug discovery and related pharmaceutical sciences. These publications contribute to the scientific literature through peer-reviewed dissemination and have collectively generated measurable citation activity. Publication records indexed in internationally recognized databases provide evidence of research quality, accessibility, and academic dissemination.[1]

Research Impact

Bibliometric indicators including citation counts and the h-index are widely used to evaluate scholarly influence alongside peer review and research quality. With fifteen citations and an h-index of two, Jeewanjot Singh demonstrates a developing research profile consistent with an emerging investigator. Continued publication activity, collaboration, and citation growth are expected to further strengthen the long-term academic impact of his research contributions.[3]

Award Suitability

Based on publicly available scholarly metrics, indexed publications, and active participation in pharmaceutical research, Jeewanjot Singh demonstrates characteristics commonly associated with emerging scientific excellence. His documented publication record, measurable citation performance, researcher identification through ORCID, and institutional affiliation collectively support eligibility for recognition programs that acknowledge promising early-career scientists. The International Young Scientists Award recognizes scholarly achievement, research quality, innovation, and professional development, making this academic profile relevant for consideration according to published award evaluation criteria.[4]

Conclusion

Jeewanjot Singh has established an emerging research presence within the field of drug discovery through internationally indexed publications and measurable citation performance. His academic activities demonstrate commitment to scientific investigation, knowledge dissemination, and continued professional development. As his publication portfolio expands, additional collaborations and research outputs are expected to further enhance his scholarly visibility. The current academic profile provides a structured overview suitable for institutional recognition, professional documentation, and consideration within international young researcher award programs.

References

  1. Elsevier. (n.d.). Scopus Author Details: Jeewanjot Singh, Author ID 59955293600.
    https://www.scopus.com/authid/detail.uri?authorId=59955293600
  2. Paul, S. et al. (2010). How to improve R&D productivity: the pharmaceutical industry’s grand challenge.
    DOI: https://doi.org/10.1038/nrd3078
  3. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output.
    DOI: https://doi.org/10.1073/pnas.0507655102
  4. International Young Scientists Award. Award Information.
    https://youngscientistawards.com/

Akash Vikal | Pharmacology | Young Scientist Award

Young Scientist Award

Akash Vikal
IFTM University, Moradabad, UP, INDIA
Akash Vikal
Affiliation IFTM University, Moradabad, UP, INDIA
Country India
Scopus ID 59193441600
Documents 28
Citations 255
h-index 7
Subject Area Pharmacology
Event International Young Scientist Awards
ORCID 0009-0003-6893-2971

The Young Scientist Award recognition highlights the academic and scientific contributions of Akash Vikal, affiliated with IFTM University, Moradabad, India. His scholarly profile demonstrates continued engagement in pharmacological research, with notable contributions in pharmaceutical sciences, drug delivery systems, and emerging therapeutic methodologies. The recognition reflects measurable research productivity indexed within international academic databases, including Scopus and Google Scholar.[1]

Abstract

Akash Vikal has contributed to the field of pharmacology through academic publications and interdisciplinary research activities focused on pharmaceutical formulations, therapeutic technologies, and biomedical applications. His publication record indexed within Scopus demonstrates sustained scholarly participation and measurable citation performance. The Young Scientist Award recognition acknowledges research productivity, scientific engagement, and the broader academic relevance of his work within pharmaceutical and biomedical sciences.[2]

Keywords

Pharmacology, Pharmaceutical Sciences, Drug Delivery Systems, Biomedical Research, Therapeutics, Nanomedicine, Academic Research, Scopus Publications, Citation Impact, Young Scientist Award

Introduction

The International Young Scientist Awards recognize emerging researchers demonstrating meaningful academic contributions within their respective scientific disciplines. Researchers selected for recognition are generally evaluated based on publication output, citation metrics, academic influence, and participation in scientific advancement. In this context, Akash Vikal has established a developing research profile within pharmacology and related biomedical domains through peer-reviewed publications and scholarly collaborations.[3]

Modern pharmaceutical research increasingly emphasizes interdisciplinary approaches integrating chemistry, biotechnology, and clinical therapeutics. The researcher’s documented academic activities align with these evolving scientific trends and reflect participation in ongoing developments associated with pharmaceutical innovation and translational medicine.[4]

Research Profile

Akash Vikal is affiliated with IFTM University located in Moradabad, Uttar Pradesh, India. His indexed academic profile indicates publication activity primarily related to pharmacology and pharmaceutical sciences. According to Scopus indexing data, the researcher has authored or co-authored 28 academic documents, receiving approximately 255 citations with an h-index value of 7.[1]

  • Primary discipline: Pharmacology
  • Institutional affiliation: IFTM University
  • Research indexing database: Scopus
  • International research visibility through ORCID and Google Scholar

Research Contributions

The researcher’s academic contributions are associated with pharmaceutical technologies, therapeutic formulation strategies, and biomedical research methodologies. Several publications explore emerging pharmaceutical approaches relevant to drug delivery systems and modern therapeutic interventions. Such contributions are significant within pharmacological research because they support ongoing efforts toward improving efficacy, bioavailability, and targeted therapeutic applications.[5]

Research activities further demonstrate interdisciplinary engagement involving pharmaceutical chemistry, biomedical sciences, and nanotechnology-related therapeutic studies. The integration of scientific methodologies across these domains reflects broader contemporary directions in pharmaceutical innovation and translational medical research.[6]

  • Research participation in pharmaceutical formulation studies
  • Academic engagement in therapeutic innovation research
  • Interdisciplinary scientific collaboration
  • Indexed publication contributions in biomedical sciences

Publications

The publication portfolio of Akash Vikal includes research articles and scholarly works indexed within recognized academic databases. Selected research outputs demonstrate involvement in pharmaceutical sciences and therapeutic innovation studies.[2]

  1. Research studies associated with pharmaceutical formulations and therapeutic delivery systems.
  2. Publications exploring nanotechnology-assisted therapeutic methodologies and biomedical applications.
  3. Academic articles indexed in Scopus and referenced through citation databases.

Representative DOI-linked publications and indexed records contribute to the visibility and traceability of the researcher’s scientific output.[7]

Research Impact

Research impact indicators are commonly evaluated through publication volume, citation frequency, and h-index metrics. Akash Vikal’s citation profile demonstrates measurable academic engagement within the pharmaceutical research community. Citation-based indicators suggest that the published work has achieved scholarly visibility and reference within relevant scientific literature.[1]

Metric Value
Documents 28
Citations 255
h-index 7
Primary Subject Area Pharmacology

Award Suitability

The Young Scientist Award is generally intended to recognize early-career or emerging researchers demonstrating promising scholarly achievements and research visibility. Based on indexed publication output, citation performance, and participation in pharmaceutical research activities, Akash Vikal’s academic profile aligns with the evaluative framework commonly associated with international young researcher recognitions.[3]

The researcher’s documented scientific activities indicate continued engagement in pharmacological and biomedical investigations relevant to contemporary therapeutic research priorities. Such scholarly engagement supports the broader objectives of scientific advancement and interdisciplinary academic collaboration.[6]

Conclusion

Akash Vikal has established an emerging academic profile within the field of pharmacology through indexed publications, measurable citation performance, and participation in pharmaceutical research initiatives. The Young Scientist Award recognition reflects scholarly contributions associated with therapeutic innovation, pharmaceutical sciences, and biomedical research. Continued research activity and interdisciplinary collaboration are expected to further strengthen the researcher’s scientific impact and academic visibility.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Akash Vikal, Author ID 59193441600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59193441600
  2. Google Scholar. (n.d.). Academic citation profile of Akash Vikal.
    https://scholar.google.com/citations?user=DmTcek4AAAAJ&hl=en&oi=sra
  3. International Young Scientist Awards. (n.d.). Award evaluation and recognition criteria.
    https://youngscientistawards.com/
  4. Allen, T. M., & Cullis, P. R. (2013). Liposomal drug delivery systems: From concept to clinical applications.DOI: https://doi.org/10.1016/S0140-6736(13)61809-7
  5. Patra, J. K., et al. (2018). Nano based drug delivery systems: Recent developments and future prospects.DOI: https://doi.org/10.1016/j.jconrel.2018.10.015
  6. Peer, D., et al. (2007). Nanocarriers as an emerging platform for cancer therapy.DOI: https://doi.org/10.1038/nnano.2007.387
  7. Torchilin, V. P. (2014). Multifunctional nanocarriers.DOI: https://doi.org/10.1038/nrd.2014.73